These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 18722890)
21. Ultrasound-Guided Botulinum Toxin Injections into the Salivary Glands for the Treatment of Drooling. Abboud WA; Nadel S; Hassin-Baer S; Arad A; Dobriyan A; Yahalom R Isr Med Assoc J; 2019 Feb; 21(2):116-119. PubMed ID: 30772963 [TBL] [Abstract][Full Text] [Related]
22. Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview. Petracca M; Guidubaldi A; Ricciardi L; Ialongo T; Del Grande A; Mulas D; Di Stasio E; Bentivoglio AR Toxicon; 2015 Dec; 107(Pt A):129-40. PubMed ID: 26327120 [TBL] [Abstract][Full Text] [Related]
23. Up-to-date report of botulinum toxin type A treatment in patients with gustatory sweating (Frey's syndrome). Laskawi R; Drobik C; Schönebeck C Laryngoscope; 1998 Mar; 108(3):381-4. PubMed ID: 9504611 [TBL] [Abstract][Full Text] [Related]
24. [Effectiveness of botulinum toxin A in the treatment of gustatory sweating]. Küttner C; Tröger M; Dempf R; Eckardt A Nervenarzt; 2001 Oct; 72(10):787-90. PubMed ID: 11688180 [TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin therapy in Frey's syndrome: a retrospective study of 440 treatments in 100 patients. Jansen S; Jerowski M; Ludwig L; Fischer-Krall E; Beutner D; Grosheva M Clin Otolaryngol; 2017 Apr; 42(2):295-300. PubMed ID: 27513469 [TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin type A for Frey's syndrome: a preliminary prospective study. Laccourreye O; Muscatelo L; Naude C; Bonan B; Brasnu D Ann Otol Rhinol Laryngol; 1998 Jan; 107(1):52-5. PubMed ID: 9439389 [TBL] [Abstract][Full Text] [Related]
27. Treatment of Frey's syndrome with botulinum toxin type B. Cantarella G; Berlusconi A; Mele V; Cogiamanian F; Barbieri S Otolaryngol Head Neck Surg; 2010 Aug; 143(2):214-8. PubMed ID: 20647122 [TBL] [Abstract][Full Text] [Related]
28. Long-term safety and efficacy data on botulinum toxin type A: an injection for sialorrhea. Chan KH; Liang C; Wilson P; Higgins D; Allen GC JAMA Otolaryngol Head Neck Surg; 2013 Feb; 139(2):134-8. PubMed ID: 23429943 [TBL] [Abstract][Full Text] [Related]
30. Treatment of gustatory sweating with low-dose botulinum toxin A: a case report. Bakke M; Max Thorsen N; Bardow A; Dalager T; Eckhart Thomsen C; Regeur L Acta Odontol Scand; 2006 Jun; 64(3):129-33. PubMed ID: 16809188 [TBL] [Abstract][Full Text] [Related]
31. Clinical efficacy of botulinum toxin in salivary duct stenosis: A preliminary study of six cases. Trapeau C; Foletti JM; Collet C; Guyot L; Chossegros C J Stomatol Oral Maxillofac Surg; 2017 Dec; 118(6):349-352. PubMed ID: 28899693 [TBL] [Abstract][Full Text] [Related]
32. The Experience of Treating Drooling with Repeated Botulinum Toxin Injections. Sillanpää S; Sipilä M; Numminen J; Rautiainen M ORL J Otorhinolaryngol Relat Spec; 2015; 77(6):333-8. PubMed ID: 26418063 [TBL] [Abstract][Full Text] [Related]
33. [Therapy of Frey syndrome with botulinum toxin A. Experiences with a new method of treatment]. Drobik C; Laskawi R; Schwab S HNO; 1995 Nov; 43(11):644-8. PubMed ID: 8530311 [TBL] [Abstract][Full Text] [Related]
34. Drooling: are botulinum toxin injections into the major salivary glands a good treatment option? Nordgarden H; Østerhus I; Møystad A; Asten P; Johnsen UL; Storhaug K; Loven JØ J Child Neurol; 2012 Apr; 27(4):458-64. PubMed ID: 21940695 [TBL] [Abstract][Full Text] [Related]
35. Clinical results in the management of Frey's syndrome with injections of Botulinum toxin. Martos Díaz P; Bances del Castillo R; Mancha de la Plata M; Naval Gías L; Martínez Nieto C; Lee GY; Muñoz Guerra M Med Oral Patol Oral Cir Bucal; 2008 Apr; 13(4):E248-52. PubMed ID: 18379450 [TBL] [Abstract][Full Text] [Related]
36. Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia. Barbero P; Busso M; Tinivella M; Artusi CA; De Mercanti S; Cucci A; Veltri A; Avagnina P; Calvo A; Chio' A; Durelli L; Clerico M J Neurol; 2015 Dec; 262(12):2662-7. PubMed ID: 26410746 [TBL] [Abstract][Full Text] [Related]
37. [Post-parotidectomy Frey's syndrome. Treatment with botulinum toxin type A]. Cavalot AL; Palonta F; Preti G; Nazionale G; Ricci E; Staffieri A; Di Girolamo S; Cortesina G Acta Otorhinolaryngol Ital; 2000 Jun; 20(3):187-91. PubMed ID: 11139877 [TBL] [Abstract][Full Text] [Related]
38. [Severe Frey syndrome after parotidectomy: treatment with botulinum neurotoxin type A]. Laccourreye O; Muscatello L; Gutierrez-Fonseca R; Seckin S; Brasnu D; Bonan B Ann Otolaryngol Chir Cervicofac; 1999 Jun; 116(3):137-42. PubMed ID: 10399528 [TBL] [Abstract][Full Text] [Related]
39. Management of Frey's syndrome and hypersialorrhea with botulinum toxin. Guntinas-Lichius O Facial Plast Surg Clin North Am; 2003 Nov; 11(4):503-13. PubMed ID: 15062255 [TBL] [Abstract][Full Text] [Related]
40. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B. Wilken B; Aslami B; Backes H Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]